Latent tuberculosis infection: recent progress and challenges in South Korea
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Management of latent tuberculosis infection (LTBI) is a critical element in the elimination of tuberculosis (TB). However, the low positive predictive value of the current diagnostic tests and the low acceptance and completion rate of the isoniazid- based regimen are major barriers to the implementation and scale-up of programmatic management of LTBI. In the past decade, there has been some progress in the conception, diagnosis, and treatment of LTBI. LTBI is now understood as a dynamic spectrum rather than the traditional binary distinction between active and latent TB. New insight into LTBI has led to a renewed interest in incipient TB, which would be a potential target for developing new diagnostics and therapeutics of LTBI. Recent studies showed that host transcriptomic signatures could be a potential biomarker for incipient TB. The new shorter rifamycin-based regimens have shown comparable efficacy, but better completion rate and safety compared to the isoniazid-based regimen. In South Korea, LTBI management has been expanded and integrated into key elements of the National Tuberculosis Control Program. For the programmatic approach to LTBI management, the following challenges need to be addressed; target group selection, treatment-related interventions, monitoring and surveillance system, and extending the plan for vulnerable groups.
Abstract
Management of latent tuberculosis infection (LTBI) is a critical element in the elimination of tuberculosis (TB). However, the low positive predictive value of the current diagnostic tests and the low acceptance and completion rate of the isoniazid- based regimen are major barriers to the implementation and scale-up of programmatic management of LTBI. In the past decade, there has been some progress in the conception, diagnosis, and treatment of LTBI. LTBI is now understood as a dynamic spectrum rather than the traditional binary distinction between active and latent TB. New insight into LTBI has led to a renewed interest in incipient TB, which would be a potential target for developing new diagnostics and therapeutics of LTBI. Recent studies showed that host transcriptomic signatures could be a potential biomarker for incipient TB. The new shorter rifamycin-based regimens have shown comparable efficacy, but better completion rate and safety compared to the isoniazid-based regimen. In South Korea, LTBI management has been expanded and integrated into key elements of the National Tuberculosis Control Program. For the programmatic approach to LTBI management, the following challenges need to be addressed; target group selection, treatment-related interventions, monitoring and surveillance system, and extending the plan for vulnerable groups.
참고문헌 (50)
- "Global tuberculosis report 2019" (2018)[URL]
- "Annual report on the notified tuberculosis patients in Korea 2018" (2019)[URL]
- Houben RM, "The global burden of latent tuberculosis infection : a re-estimation using mathematical modelling", PLoS Med, 13, pp.e1002152~ (2016)
- Comstock GW, "The prognosis of a positive tuberculin reaction in childhood and adolescence", Am J Epidemiol, 99, pp.131~138 (1974)
- Dye C, "Prospects for tuberculosis elimination", Annu Rev Public Health, 34, pp.271~286 (2013)
- Menzies NA, "Prospects for tuberculosis elimination in the United States : results of a transmission dynamic model : version 2", Am J Epidemiol, 187, pp.2011~2020 (2018)
- Uplekar M, "WHO’s new end TB strategy", Lancet, 385, pp.1799~1801 (2015)
- "Latent TB infection: updated and consolidated guidelines for programmatic management" (2018)[URL]
- Barry CE 3rd, "The spectrum of latent tuberculosis : rethinking the biology and intervention strategies", Nat Rev Microbiol, 7, pp.845~855 (2009)
- Esmail H, "Understanding latent tuberculosis : the key to improved diagnostic and novel treatment strategies", Drug Discov Today, 17, pp.514~521 (2012)
- Achkar JM, "Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response", J Infect Dis, 204(Suppl 4), pp.S1179~S1186 (2011)
- Drain PK, "Incipient and subclinical tuberculosis : a clinical review of early stages and progression of infection", Clin Microbiol Rev, 31, pp.e00021-18~ (2018)
- "Consensus meeting report:development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease" (2017)[URL]
- Haas MK, "Diagnostic tests for latent tuberculosis infection", Clin Chest Med, 40, pp.829~837 (2019)
- Kristen Overton, "Comparison of Interferon-γ Release Assays and the Tuberculin Skin Test for Diagnosis of Tuberculosis in Human Immunodeficiency Virus: A Systematic Review", Tuberculosis and Respiratory Diseases, 81(1), pp.59~72 (2018), 대한결핵및호흡기학회
- Matteelli A, "Numbers needed to treat to prevent tuberculosis", Eur Respir J, 46, pp.1838~1839 (2015)
- Diel R, "Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state : a meta-analysis", Chest, 142, pp.63~75 (2012)
- Soo Han Kim, "QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection", The Korean Journal of Internal Medicine, 35(2), pp.383~391 (2020), 대한내과학회[DOI]
- Sotgiu G, "QuantiFERON TB Gold Plus for the diagnosis of tuberculosis : a systematic review and meta-analysis", J Infect, 79, pp.444~453 (2019)
- Aggerbeck H, "C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults : a phase 3 trial", PLoS One, 13, pp.e0204554~ (2018)
- Ruhwald M, "Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γrelease assay and the tuberculin skin test : a phase 3, double-blind, randomised, controlled trial", Lancet Respir Med, 5, pp.259~268 (2017)
- Goletti D, "Update on tuberculosis biomarkers : from correlates of risk, to correlates of active disease and of cure from disease", Respirology, 23, pp.455~466 (2018)
- Singhania A, "The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis", Nat Immunol, 19, pp.1159~1168 (2018)
- Suliman S, "Four-gene pan-African blood signature predicts progression to tuberculosis", Am J Respir Crit Care Med, 197, pp.1198~1208 (2018)
- Penn-Nicholson A, "Discovery and validation of a prognostic proteomic signature for tuberculosis progression : a prospective cohort study", PLoS Med, 16, pp.e1002781~ (2019)
- Alsdurf H, "The cascade of care in diagnosis and treatment of latent tuberculosis infection : a systematic review and meta-analysis", Lancet Infect Dis, 16, pp.1269~1278 (2016)
- 김형우, "Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy", Tuberculosis and Respiratory Diseases, 81(1), pp.6~12 (2018), 대한결핵및호흡기학회
- Menzies D, "Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults", N Engl J Med, 379, pp.440~453 (2018)
- Sterling TR, "Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons", AIDS, 30, pp.1607~1615 (2016)
- Swindells S, "One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis", N Engl J Med, 380, pp.1001~1011 (2019)
- Jonathon R Campbell, "Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials", The Lancet Infectious Diseases, 20(3), pp.318~329 (2020), Elsevier BV[DOI]
- Jo KW, "Adverse event and treatment completion rates of a 12-dose weekly isoniazid and rifapentine course for South Korean healthcare workers", Respir Med, 158, pp.42~48 (2019)
- Tait DR, "Final analysis of a trial of M72", AS01E vaccine to prevent tuberculosis, 2019, pp.381, 2429~2439
- 조경숙, "Tuberculosis control in the Republic of Korea", Epidemiology and Health, 40, pp.1~6 (2018), 한국역학회[DOI]
- 7th Korea National Health and Nutrition Examination Survey, 1st Year (2016): Tuberculin Survey Support and Quality Control, "Korean National Tuberculosis Association", Korea Centers for Disease Control and Prevention, ~ (2017)
- Kim SJ, "Incidence of pulmonary tuberculosis in Korean civil servants", Tuber Lung Dis, 76, pp.534~539 (1995)
- Choi JK, "The prevalence of latent tuberculosis infection in congregated settings in the Republic of Korea, 2018", Public Health Wkly Rep, 12, pp.786~792 (2019)
- Cho KS, "Prevalence of latent tuberculosis infection at congregated settings in the Republic of Korea, 2017", Public Health Wkly Rep, 11, pp.348~354 (2018)
- 박재석, "The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea", Tuberculosis and Respiratory Diseases, 81(4), pp.274~280 (2018), 대한결핵및호흡기학회
- Go U, "Tuberculosis prevention and care in Korea : evolution of policy and practice", J Clin Tuberc Other Mycobact Dis, 11, pp.28~36 (2018)
- 이승헌, "잠복결핵의 진단과 치료: 2017 개정 지침을 중심으로", 대한내과학회지, 93(6), pp.509~517 (2018), 대한내과학회
- Rangaka MX, "Controlling the seedbeds of tuberculosis : diagnosis and treatment of tuberculosis infection", Lancet, 386, pp.2344~2353 (2015)
- Campbell JR, "Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries", PLoS Med, 16, pp.e1002824~ (2019)
- 배종면, "An opposing view on including high school students in a latent tuberculosis infection control program in Korea", Epidemiology and Health, 39, pp.1~3 (2017), 한국역학회[DOI]
- 이상윤, "Pre-immigration Screening for Tuberculosis in South Korea: A Comparison of Smear- and Culture-Based Protocols", Tuberculosis and Respiratory Diseases, 82(2), pp.151~157 (2019), 대한결핵및호흡기학회[DOI]
- 김병기, "Experiences of Latent Tuberculosis Infection Treatment for the North Korean Refugees", Tuberculosis and Respiratory Diseases, 82(4), pp.306~310 (2019), 대한결핵및호흡기학회[DOI]
- 김재경, "Tuberculosis Relief Belt Supporting Project (Tuberculosis Patient Management Project for Poverty Group)", Tuberculosis and Respiratory Diseases, 81(3), pp.241~246 (2018), 대한결핵및호흡기학회
- Hyung Woo Kim, "One Step toward a Low Tuberculosis-Burden Country: Screening for Tuberculosis Infection among the Immigrants and Refugees", Tuberculosis and Respiratory Diseases, 83(1), pp.104~105 (2020), 대한결핵및호흡기학회[DOI]
- 이승헌, "Active Case Finding in the Elderly Tuberculosis in South Korea", Tuberculosis and Respiratory Diseases, 82(3), pp.261~263 (2019), 대한결핵및호흡기학회
- 김현우, "A Pilot Project of Systematic Tuberculosis Screening in the Elderly in a South Korean Province", Tuberculosis and Respiratory Diseases, 82(3), pp.194~200 (2019), 대한결핵및호흡기학회